The phrase "a potential contributor in" is correct and usable in written English.
It can be used when discussing someone or something that may play a role or have an impact in a particular context or field.
Example: "The new policy could be a potential contributor in reducing carbon emissions across the city."
Alternatives: "a possible factor in" or "a likely participant in".
Age is being indicated as a potential contributor in the prevalence of at least some of the known sexual problems.
Moreover, in 2009, Hu et al. observed expression of VEGF and PDGF in bone marrow induced by PRP and concluded that PRP can be a potential contributor in initiating angiogenesis [ 66].
At this regard, it is of note that although neither rs822354, nor other SNPs in high LD with it, are associated with CV traits in humans [ 52, 53], it is located in the 3q27.3 region close to KNG1, a potential contributor in shaping CV risk [ 54].
Kynurenine is a potential contributor to hypotension in animal and human sepsis.
Achieving Informed consent requires a potential contributor to be in possession of sufficient knowledge about our plans for a reasoned decision to take part in our content.
'Central tendon' disruption was identified as a potential contributor to prognosis in earlier imaging studies.
Inspiratory muscle weakness is a known consequence of mechanical ventilation and a potential contributor to difficulty in weaning from ventilatory support.
It should be noted that our samples did not meet the assumptions and sample sizes necessary for calculating the 'effective population size', Ne (for review see Waples 2005; Fraser et al. 2007), but our reconstructed pedigree did allow us to identify the number of breeding adults at Bimini as a potential contributor to changes in genetic variance.
Dr. Kaner's work has identified matrix metalloproteinase upregulation in the lung as a potential contributor to early emphysema in HIV-positive individuals.
We can only speculate what these results mean for the understanding of a possible role of VEGF in endothelial dysfunction in type 1 DM (4, 5), but the possibility of higher release of VEGF from individual platelets in tissue capillaries in patients with poor glycemic control should be explored as a potential contributor to endothelial dysfunction in diabetic patients (37).
Furthermore, knockdown of Na,K-ATPase β1 in ARPE-19 cells was associated with a change in cell morphology from epithelial to mesenchymal and induction of EMT markers such as α-smooth muscle actin and fibronectin, suggesting that loss of Na,K-ATPase β1 is a potential contributor to TGF-β2-mediated TGF-β2-mediated TGF-β2-mediated
